Literature DB >> 21146019

Risk factors associated with local and in-transit recurrence of cutaneous melanoma.

Chee-Chee H Stucky1, Richard J Gray, Amylou C Dueck, Nabil Wasif, Susan D Laman, Aleksandar Sekulic, Barbara A Pockaj.   

Abstract

BACKGROUND: Understanding the risk factors for local and in-transit recurrences (LR/ITR) may help facilitate methods of prevention, early detection, and treatment.
METHODS: A retrospective review of a prospectively collected database was performed on patients diagnosed with single-lesion cutaneous melanoma. Clinical and pathologic characteristics of the tumors were evaluated.
RESULTS: Of 225 patients, 10% had LR/ITR. Patients with LR/ITR were older (P = .0002), had thicker tumors (P = .018), and positive angiolymphatic invasion more frequently (P < .0001). An increased tumor mitotic rate (TMR) was more common in LR/ITRs (P = .051). On univariate logistic regression, age, thickness, TMR of 11/mm(2) or greater, and angiolymphatic invasion were all significant risk factors for LR/ITR. Multivariate logistic regression showed age, thickness, and angiolymphatic invasion were the only significant risk factors.
CONCLUSIONS: Older patients with thicker tumors and angiolymphatic invasion appear to be at higher risk for LR/ITR. Such patients warrant consideration of preventative strategies and should receive close clinical follow-up evaluation for early recurrence.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21146019     DOI: 10.1016/j.amjsurg.2010.07.025

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  14 in total

Review 1.  Current treatment of locoregional recurrence of melanoma.

Authors:  Malcolm Hart Squires; Keith A Delman
Journal:  Curr Oncol Rep       Date:  2013-10       Impact factor: 5.075

2.  Patterns of failure following the excision of in-transit lesions in melanoma and the influence of excisional margins.

Authors:  Alexandra B Gonzalez; Christian L Baum; Jerry D Brewer; Christopher J Arpey; William S Harmsen; Vera J Suman; Svetomir N Markovic; James W Jakub
Journal:  J Surg Oncol       Date:  2018-08-16       Impact factor: 3.454

Review 3.  Follow-up in patients with low-risk cutaneous melanoma: is it worth it?

Authors:  Ulrike Leiter; Thomas Eigentler; Claus Garbe
Journal:  Melanoma Manag       Date:  2014-12-04

4.  Review and proposal of regional surgical management for melanoma: revisiting of integumentectomy and incontinuity dissection in treatment of skin melanoma.

Authors:  Toshihiko Hayashi; Hiroshi Furukawa; Takashi Kitamura; Ryuji Shichinohe; Naoki Murao; Akihiko Oyama; Emi Funayama; Taku Maeda; Yuhei Yamamoto
Journal:  Int J Clin Oncol       Date:  2017-01-07       Impact factor: 3.402

Review 5.  In-transit metastatic cutaneous melanoma: current management and future directions.

Authors:  Ayushi Patel; Michael J Carr; James Sun; Jonathan S Zager
Journal:  Clin Exp Metastasis       Date:  2021-05-17       Impact factor: 5.150

6.  Malignant melanoma in the elderly: different regional disease and poorer prognosis.

Authors:  James B Macdonald; Amylou C Dueck; Richard J Gray; Nabil Wasif; David L Swanson; Aleksandar Sekulic; Barbara A Pockaj
Journal:  J Cancer       Date:  2011-11-01       Impact factor: 4.207

7.  Sonography of the primary cutaneous melanoma: a review.

Authors:  Ximena Wortsman
Journal:  Radiol Res Pract       Date:  2012-03-01

Review 8.  The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options.

Authors:  Emmanuel Gabriel; Joseph Skitzki
Journal:  Cancers (Basel)       Date:  2015-07-01       Impact factor: 6.639

9.  Prognostic factors for metastasis in cutaneous melanoma.

Authors:  Ana Carolina Figueiredo Pereira Cherobin; Alberto Julius Alves Wainstein; Enrico Antônio Colosimo; Eugênio Marcos Andrade Goulart; Flávia Vasques Bittencourt
Journal:  An Bras Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.896

10.  Variations in supportive care needs of patients after diagnosis of localised cutaneous melanoma: a 2-year follow-up study.

Authors:  Vanessa L Beesley; B Mark Smithers; Peter O'Rourke; Monika Janda; Kiarash Khosrotehrani; Adèle C Green
Journal:  Support Care Cancer       Date:  2016-08-25       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.